[1]
H. Nugroho, “Effectiveness and Safety of DLBS3233 in Newly Diagnosed Type 2 Diabetes Mellitus: A 12-week Clinical Trial”, Acta Med Indones, vol. 56, no. 3, p. 291, Oct. 2024.